IPO registrations (S-1, F-1) · Registrants

CHIMERIX INC

SEC CIK
1117480 · filings on EDGAR ↗
Registration
Form S-1, first filed 2013-03-08, last 2013-10-17; 2 initial registrations, 3 amendments
Outcome
Final prospectus filed 2013-04-11; declared effective 2013-04-10
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
2505 MERIDIAN PARKWAY, SUITE 100, Durham, NC 27713
EIN
33-0903395
EDGAR entity type
operating
Insiders and CEO pay
CHIMERIX INC on the corporate pages

Offering terms

Proposed price range
$13.00–$15.00 per share (S-1/A filed 2013-04-01)
Final price
$14.00 per share, within the range (424B4 filed 2013-04-11, an initial public offering)
Shares sold
7,320,000
Gross proceeds
$102,480,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol CMRX
Lead underwriters
Morgan Stanley (3,294,000 shares); Cowen (2,196,000 shares)
Syndicate
William Blair (1,098,000); Lazard (732,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 11

FiledFormWhat it isName as filedEDGAR
2013-03-08S-1S-1 (registration)CHIMERIX INC0001144204-13-014056 ↗
2013-03-27S-1/AS-1/A (amendment)CHIMERIX INC0001144204-13-017647 ↗
2013-04-01S-1/AS-1/A (amendment)CHIMERIX INC0001144204-13-018850 ↗
2013-04-10S-1MEFS-1MEF (added securities)CHIMERIX INC0001144204-13-021187 ↗
2013-04-10EFFECTEFFECT (declared effective)CHIMERIX INC9999999995-13-000950 ↗
2013-04-11424B4424B4 (final prospectus)CHIMERIX INC0001144204-13-021201 ↗
2013-10-08S-1S-1 (registration)CHIMERIX INC0001144204-13-054339 ↗
2013-10-17S-1/AS-1/A (amendment)CHIMERIX INC0001144204-13-055496 ↗
2013-10-18424B4424B4 (final prospectus)CHIMERIX INC0001144204-13-055804 ↗
2013-10-18EFFECTEFFECT (declared effective)CHIMERIX INC9999999995-13-003021 ↗
2014-05-16EFFECTEFFECT (declared effective)CHIMERIX INC9999999995-14-001515 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2013-04-01S-1/Aregistration statement$13.00–$15.006,100,000-Nasdaq CMRX4primary document; range, shares headline, cover names 4document ↗
2013-04-11424B4final prospectus$14.007,320,000$102,480,000Nasdaq CMRX4primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KGOther; TenPercentOwner22013
ALTA BIOPHARMA PARTNERS III LPOther; TenPercentOwner22013
ALTA EMBARCADERO BIOPHARMA PARTNERS III LLCOther; TenPercentOwner22013
A.M. Pappas Life Science Ventures III, L.P.Other; TenPercentOwner22013
A.M. Pappas Life Science Ventures IV LPOther; TenPercentOwner22013
Berrey M MichelleDirector,Officer; OfficerChief Medical Officer; Pres, CEO & Chief Medical Ofcr; President and CEO; See Remarks292013–2019
Canaan Partners VII LLCDirector; Director,TenPercentOwner; TenPercentOwner62013–2014
Canaan VII L PDirector; Director,TenPercentOwner; TenPercentOwner62013–2014
CHAMPSI FARAHDirector; Director,TenPercentOwner32013
DEMSKI MARTHA JDirector342013–2025
Hutton Wende SDirector,TenPercentOwner42013person page Fuzzy
MARIO ERNESTDirector402013–2018
MOCH KENNETH IDirector,OfficerPresident and CEO72013–2014
New Leaf Ventures II, L.P.TenPercentOwner52013–2014
NIEDEL JAMESDirector; Director,TenPercentOwner92013–2017
PAPPAS ARTHUR MDirector; Director,TenPercentOwner32013
PV III CEO Fund, L.P.Other; TenPercentOwner22013
PV IV CEO Fund, L.P.Other; TenPercentOwner22013
Rogers Michael D.OfficerChief Development Officer62013–2016
SANDERLING V BETEILIGUNGS GMBH & CO KGTenPercentOwner42013
SANDERLING V BIOMEDICAL CO INVESTMENT FUND LPTenPercentOwner42013
SANDERLING V BIOMEDICAL LPTenPercentOwner42013
Sanderling Venture Partners V Co Investment Fund, LPTenPercentOwner42013
Sanderling Venture Partners VI Co Investment Fund LPTenPercentOwner52013–2014
Sanderling Venture Partners V, LPTenPercentOwner102013–2014
SANDERLING VENTURES MANAGEMENT VTenPercentOwner42013
Sanderling Ventures Management VITenPercentOwner42013
Sanderling VI Beteiligungs GmbH & Co KGTenPercentOwner42013
Sanderling VI Limited PartnershipTenPercentOwner42013
SANDERLING V LTD PARTNERSHIPTenPercentOwner42013
Sanderling V Strategic Exit Fund LPTenPercentOwner42013
Trost Timothy W.OfficerSee Remarks; Sr. Vice President and CFO; Sr. VP and CFO; Sr. VP & CFO; SVP and CFO; SVP, CFO & Secretary312013–2019
WOLLAEGER TIMOTHYDirector; Director,TenPercentOwner102013–2016
DRAKE RODMAN LDirector72013–2014
Richardson Linda MOfficerChief Commercial Officer; Chief Commerical Officer112014–2018
Chambon Philippe O.TenPercentOwner22014
Delagardelle JeaniTenPercentOwner22014
HUNT RONALDTenPercentOwner22014
Lathi Vijay KTenPercentOwner22014
New Leaf Venture Associates II, L.P.TenPercentOwner22014
New Leaf Venture Management II, L.L.C.TenPercentOwner22014
Ratcliffe LiamTenPercentOwner22014
Ricciardi LisaDirector62014–2016
Daly James MDirector72014–2019
Gilliss CatherineDirector112014–2023
Machado Clarence PatrickDirector122014–2023
LEONARD JOHN M.Director82014–2017
Nichols GarrettOfficerChief Medical Officer202014–2020
Renaud Ronald C JRDirector72014–2019
Greissing EdDirector52018–2020
Meyer Robert J.Director152018–2025
MIDDLETON FRED ADirector212018–2025
Alrutz Michael AlbertOfficerPrincipal Executive Officer; SVP AND GENERAL COUNSEL82019–2025
Andriole Michael T.Director,Officer; OfficerChief Business Officer; Chief Business Officer and CFO; President and CEO; PRESIDENT AND CEO202019–2025
Sherman Michael A.Director,OfficerChief Executive Officer132019–2025person page Fuzzy
Jakeman DavidOfficerPrincipal Accounting Officer; VP of Finance and Accounting; VP OF FINANCE AND ACCOUNTING242019–2025
CANTEX PHARMACEUTICALS, INC.TenPercentOwner32019–2021
Multani Pratik SDirector82020–2025
Melemed Allen S.OfficerChief Medical Officer; CHIEF MEDICAL OFFICER92020–2025
Vakiener VictoriaDirector72021–2025
Riga Thomas JOfficerCOO and CCO42023–2025
LaSpaluto MichelleOfficerChief Financial Officer; CHIEF FINANCIAL OFFICER82023–2025
Decker Lisa LynnDirector42024–2025
KOZIN MARC DDirector42024–2025

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2019-07-31CHIMERIX INCPharmaceuticals$34,900,000$34,900,00011

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationCHIMERIX, INC.NCState business registriesname and state
Plan sponsorCHIMERIX, INC.NCForm 5500 (employee benefit plans)name and state
Federal award recipientCHIMERIX, INC.NCFederal spending (USAspending)name and state
Form D issuerCHIMERIX INCNCForm D private offeringsCIK (EXACT)
Lobbying clientCHIMERIX, INC.NCFederal lobbying (LDA)name and state
Lobbying clientCHIMERIX, INC.NCFederal lobbying (LDA)name and state
Lobbying clientCHIMERIX, INC.NCFederal lobbying (LDA)name and state
Lobbying clientCHIMERIX, INC.NCFederal lobbying (LDA)name and state
Patent assigneeCHIMERIX, INC.NCPatents (USPTO)name and state
SEC filerCHIMERIX INCSEC filers (EDGAR)CIK (EXACT)
Trademark ownerChimerix, Inc.NCTrademarks (USPTO)name and state
Business registrationCHIMERIX, INC.State business registriesEIN (EXACT, as the state registration reports it)
Business registrationCHIMERIX,INCState business registriesEIN (EXACT, as the state registration reports it)
Form 5500 plan sponsorCHIMERIX, INC.EIN (EXACT)
Person pageMichael A ShermanPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)
Person pageWende S HuttonPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, NC first:

More with this interest.

In other datasets, the same topic (Health) in NC:

Interests: Pharmaceutical Preparations · Health